DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/xdxmkt/epidemiological) has announced the addition of the "Epidemiological Literature: Understanding Analyst and Vendor Derived Estimates" report to their offering.
In general, epidemiological estimates are approximated quantitative measurements, values or proportions derived from various sources and methods. In public health and clinical research, estimates are commonly used to describe the prevalence of disease in a population (i.e., disease burden), to understand the morbidity and mortality caused by specific pathogens (i.e., rate of transmissibility or case-fatality) or to serve as the basis (i.e., baseline) for risk assessments and programmatic performance improvement.
In this recent white paper the authors look at the biases inherent in both the published literature and vendor estimates of epidemiology data. From noise in the literature to estimates with agendas to vendors trying to squeeze a single number or range estimate into a complex disease state, this paper shows the need to understand the published literature behind a vendor or analyst epidemiology estimate
Key Topics Covered:
- What Are Epidemiological Estimates,
- And Why Do We Need Them?
- Where Can Accurate And Reliable Estimates Be Found?
- Estimates Obtained From The Literature
- Inherent Noise In The Literature
- That May Affect The Quality Of Estimates
- Case Study: Lesson Learned From Vioxx
- Case Study: Expert Panel Opinion
- Estimates Obtained From Sme
- S Or Vendors
- Case Study: Saturated Fat And Cardiovascular Disease
- Case Study: Tobacco Industry, World Health Organization
- And Medical Literature
- One Estimate/One Number
- Additional Resources
- Literature Databases
- Timely Data Resources And Thomson Reuters
For more information visit http://www.researchandmarkets.com/research/xdxmkt/epidemiological